financetom
Business
financetom
/
Business
/
Alteryx Insider Bought Shares Worth $440,953, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alteryx Insider Bought Shares Worth $440,953, According to a Recent SEC Filing
Mar 12, 2024 6:15 AM

08:49 AM EDT, 03/12/2024 (MT Newswires) -- Christopher M Lal, CLO & Corp. Secretary, on March 08, 2024, executed a purchase for 9,156 shares in Alteryx ( AYX ) for $440,953. Following the Form 4 filing with the SEC, Lal has control over a total of 118,001 shares of the company, with 118,001 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1689923/000168992324000020/xslF345X03/wk-form4_1710197943.xml

Price: 48.3, Change: +0.07, Percent Change: +0.15

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BridgeBio Pharma Says Infigratinib Receives US FDA Breakthrough Therapy Designation
BridgeBio Pharma Says Infigratinib Receives US FDA Breakthrough Therapy Designation
Sep 17, 2024
07:57 AM EDT, 09/17/2024 (MT Newswires) -- BridgeBio Pharma ( BBIO ) said Tuesday that the US Food and Drug Administration has granted Breakthrough Therapy Designation to oral infigratinib, which the biopharmaceutical company is developing to treat children with achondroplasia. Shares of BridgeBio Pharma ( BBIO ) were up 1.8% in recent Tuesday premarket activity. Price: 26.75, Change: +0.56, Percent...
Flow Beverage Q3 Adjusted Loss Narrows as Net Revenue Rises
Flow Beverage Q3 Adjusted Loss Narrows as Net Revenue Rises
Sep 17, 2024
07:54 AM EDT, 09/17/2024 (MT Newswires) -- Flow Beverage ( FLWBF ) on Tuesday said its third-quarter adjusted loss narrowed while net revenue rose slightly. The water company said its adjusted net loss fell to $5.6 million from $12.25 million in the year-ago quarter. Consolidated net revenue rose 5% to $13.8 million. Brand net revenue contracted 15% to $8.4 million,...
Vigil Neuroscience Says FDA Lifts Partial Hold on Phase 1 Trial of Potential Alzheimer's Drug
Vigil Neuroscience Says FDA Lifts Partial Hold on Phase 1 Trial of Potential Alzheimer's Drug
Sep 17, 2024
07:49 AM EDT, 09/17/2024 (MT Newswires) -- Vigil Neuroscience ( VIGL ) said Tuesday that the US Food and Drug Administration has removed the partial hold on its phase 1 clinical trial of VG-3927, a potential therapy for Alzheimer's disease, based on a complete response it submitted to the agency. The company said it has started dosing a group of...
Top Premarket Decliners
Top Premarket Decliners
Sep 17, 2024
07:48 AM EDT, 09/17/2024 (MT Newswires) -- Netcapital ( NCPL ) shares slumped 28% pre-bell Tuesday after the company reported a wider fiscal Q1 loss on lower revenue. Bone Biologics ( BBLG ) shares fell 15%, paring Monday's 136% rally. Dermata Therapeutics ( DRMA ) shares were down 9% after the company priced a $3.5 million private placement of common...
Copyright 2023-2026 - www.financetom.com All Rights Reserved